DIO Corporation (KOSDAQ:039840)
South Korea · Delayed Price · Currency is KRW 12,340
-280 (-2.22%)
Jul 20, 2026, 1:27 PM KST
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 166.24 billion as of July 17, 2026. Its market cap has decreased by -37.50% in one year.
Market Cap
166.24B
Enterprise Value
205.31B
Revenue
169.60B
Ranking
n/a
PE Ratio
21.15
Stock Price
12,340.00
ChartMarket Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 166.24B, an increase of 553.95%. That is a compound annual growth rate of 7.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 166.24B | -26.49% |
| Dec 30, 2025 | 226.14B | 1.27% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| HLB Therapeutics | 171.62B |
| Interojo | 171.03B |
| Daewon Pharmaceutical | 170.61B |
| JETEMA, | 165.93B |